BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11260267)

  • 41. Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells.
    Chernova O; Cowell JK
    Cancer Genet Cytogenet; 1998 Aug; 105(1):60-8. PubMed ID: 9689932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
    Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
    Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of a new cell line derived from a human gliosarcoma.
    Iwasaki K; Kikuchi H; Miyatake S; Kondo S; Oda Y
    Neurosurgery; 1992 Feb; 30(2):228-35. PubMed ID: 1545891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.
    Watanabe A; Ogiwara H; Ehata S; Mukasa A; Ishikawa S; Maeda D; Ueki K; Ino Y; Todo T; Yamada Y; Fukayama M; Saito N; Miyazono K; Aburatani H
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12384-9. PubMed ID: 21750150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peg3/Pw1 is involved in p53-mediated cell death pathway in brain ischemia/hypoxia.
    Yamaguchi A; Taniguchi M; Hori O; Ogawa S; Tojo N; Matsuoka N; Miyake S; Kasai K; Sugimoto H; Tamatani M; Yamashita T; Tohyama M
    J Biol Chem; 2002 Jan; 277(1):623-9. PubMed ID: 11679586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allele and dosage specificity of the Peg3 imprinted domain.
    Bretz CL; Frey WD; Teruyama R; Kim J
    PLoS One; 2018; 13(5):e0197069. PubMed ID: 29734399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trans-allelic mutational effects at the Peg3 imprinted locus.
    Bretz CL; Kim J
    PLoS One; 2018; 13(10):e0206112. PubMed ID: 30335829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.
    Dowdy SC; Gostout BS; Shridhar V; Wu X; Smith DI; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Oct; 99(1):126-34. PubMed ID: 16023706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q loss.
    Peters N; Smith JS; Tachibana I; Lee HK; Pohl U; Portier BP; Louis DN; Jenkins RB
    Neurogenetics; 1999 Sep; 2(3):163-6. PubMed ID: 10541589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
    Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
    Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal prenatal depression is associated with decreased placental expression of the imprinted gene PEG3.
    Janssen AB; Capron LE; O'Donnell K; Tunster SJ; Ramchandani PG; Heazell AE; Glover V; John RM
    Psychol Med; 2016 Oct; 46(14):2999-3011. PubMed ID: 27523184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PEG3 controls lipogenesis through ACLY.
    Ghimire S; Kim J
    PLoS One; 2021; 16(5):e0252354. PubMed ID: 34048454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcription-driven DNA methylation setting on the mouse Peg3 locus.
    Bretz CL; Kim J
    Epigenetics; 2017; 12(11):945-952. PubMed ID: 28925797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. YY1 as a controlling factor for the Peg3 and Gnas imprinted domains.
    Kim JD; Hinz AK; Choo JH; Stubbs L; Kim J
    Genomics; 2007 Feb; 89(2):262-9. PubMed ID: 17067777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.
    Ohkawa Y; Zhang P; Momota H; Kato A; Hashimoto N; Ohmi Y; Bhuiyan RH; Farhana Y; Natsume A; Wakabayashi T; Furukawa K; Furukawa K
    Cancer Sci; 2021 Sep; 112(9):3756-3768. PubMed ID: 34145699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.
    Brockschmidt A; Trost D; Peterziel H; Zimmermann K; Ehrler M; Grassmann H; Pfenning PN; Waha A; Wohlleber D; Brockschmidt FF; Jugold M; Hoischen A; Kalla C; Waha A; Seifert G; Knolle PA; Latz E; Hans VH; Wick W; Pfeifer A; Angel P; Weber RG
    Brain; 2012 Apr; 135(Pt 4):1027-41. PubMed ID: 22427331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of genomic imprinting of PPP1R9A, NAP1L5 and PEG3 in pigs.
    Jiang CD; Li S; Deng CY
    Genetika; 2011 Apr; 47(4):537-42. PubMed ID: 21675243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA-Binding Motif of the Imprinted Transcription Factor PEG3.
    Lee S; Ye A; Kim J
    PLoS One; 2015; 10(12):e0145531. PubMed ID: 26692216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
    BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.